Seipin is a widely expressed protein but with highest levels found in the brain and testes. Seipin function is not yet completely understood, therefore the aim of this study was to evaluate the expression of BSCL2 transcripts in the central nervous system Confocal microscopy studies showed that both seipin and PEX16 are closely expressed in the hypothalami of healthy human brains, and PEX16 was absent in the same region of the PELD case. We hypothesize that seipin has specific CNS functions and may play a role in peroxisome biogenesis.
Introduction
The BSCL2 gene encodes seipin, a resident endoplasmic reticulum (ER) protein with two transmembrane domains, a luminal loop, and two amino and carboxy-terminal tails in the cytoplasm.
The BSCL2 gene principally encodes three seipin isoforms under natural conditions, 462 (BSCL2-203, ENST00000360796.9; CCDS44627), 398 (BSCL2-205/207/210, ENST00000403550.5; ENST00000407022.7; ENST00000421906.5; CCDS8031), and 287 (BSCL2-201, ENST00000278893.11; CCDS55769) amino acids long, respectively. -210/207/205 was the first transcript to be described (Magre et al., 2001) , and BSCL2-203 is the same as BSCL2-210/207/205 except for an N-terminal extension of 64 amino acids encoded by exon 1 and part of exon 2. The protein translated from the short transcript is different from the other transcripts, as exon 7 is skipped in BSCL2-201 and the reading frame is different from exon 6 to exon 10 (Guillen-Navarro et al.,
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2013).
In humans, seipin forms 12 unit homoligomers that form a toroid (Sim et al., 2013; Sim et al., 2014) . BSCL2 variants can cause different diseases, such as generalized congenital lipodystrophy type 2 (MIM: # 269700), seipinopathies of first and/or second motor neurons (MIM: # 600794, MIM: # 270685) (Ito and Suzuki, 2009), or Progressive Encephalopathy with or without lipodystrophy, also called Celia's Encephalopathy (PELD, MIM: # 615924) (Guillen-Navarro et al., 2013) .
PELD is an infantile neurodegenerative disease with a fatal prognosis before 9 years previously described by our group (Guillen-Navarro et al., 2013) . Neurological regression of Celia's Encephalopathy begins at age 3-4, with early signs of severe myoclonic epilepsy, spastic tetraparesis, and severe encephalopathy leading to death before age 9. This disease is extraordinarily rare, and is a consequence of the BSCL2 gene c.985C>T variant in homozygosis or compound heterozygosis (Alaei et al., 2016; Guillen-Navarro et al., 2013) . This variant gives rise to a branch site in exon 7 of the BSCL2 gene, producing the intronization of that exon leading to an aberrant seipin with a different amino acid sequence than wild-type (BSCL2-203) from exon 6 (Guillen- Navarro et al., 2013) . The formation of large aberrant seipin macroaggregates leading to ER stress and nuclear accumulation of this abnormal protein are the pathogenetic mechanisms ultimately responsible for Celia's Encephalopathy (Ruiz-Riquelme et al., 2015) .
Seipin is a highly evolutionarily conserved protein functioning primarily to modulate the formation of lipid droplets and identified in yeast, Saccharomyces cerevisae, Caenorhabditis elegans, zebrafish, fruit fly, and mammals (Cartwright and Goodman, 2012; Salo et al., 2016; Wang et al., 2016) . While this gene is mainly expressed in the central nervous system (CNS), pituitary gland, and testis in humans (Guillen-Navarro et al., 2013; Magre et al., 2001) , little is known about the function of seipin in the CNS.
Recent studies in seipin KO mice have shown a particular action for this protein in the CNS that appears to be mediated by peroxisome proliferator-activated receptor gamma (PPARG) and that influences synaptic transmission primarily through α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors, and also promotes neuronal differentiation and modulates the behavior and motor skills of these animals (Ebihara et al., 2015; Li et al., 2015; Zhou et al., 2016) . Here we evaluate the expression of the various BSCL2 transcripts across human brain regions and extraneural tissues and investigate the putative functions of seipin in the CNS.
Experimental procedures
This study was approved by the Ethics Review panel of Xunta de Galicia (Spain) and performed in accordance with the ethical guidelines of the Helsinki Declaration.
Tissue samples
Thirteen post-mortem donors were selected, 7 men and 6 women (aged 21 to 86 years), primarily deceased by suicide, traffic accident, or natural causes (Table 1) in accordance with the current Spanish legislation, and tissue samples were obtained during autopsy conducted within 24 hours of death. Brains were removed and sliced coronally into 12 sections. The frontal cortices in the third slice, parietal and temporal cortices with hippocampi in the seventh slice, occipital lobes in the eleventh, insular cortices, amygdalae, thalami, heads of caudate and putamen nuclei, and cerebellum samples were accurately dissected and collected separately from both cerebral and cerebellar hemispheres, along with the right and left sides of the hypothalamus, mesencephalon, protuberance, and medulla oblongata, as well as the dorsal and ventral spinal cord, anterior pituitary, vagus and trigeminal nerves, skeletal muscles (rectus abdominis and gastrocnemius), adipose tissue from Bichat's fat pad, abdominal subcutaneous tissue, visceral areas and lower limbs, renal cortex and medulla, and liver and gonad samples.
These tissues were immediately submerged in liquid nitrogen after removal and subsequently stored at -80 ºC until RNA preparation. These dissections yielded a total of 44 tissues for real-time RT-PCR analysis.
RNA extraction and retrotranscription
Total RNA was isolated with the ReliaPrep™ RNA Tissue Miniprep System (Promega, Madrid, Spain). Frozen tissue samples (20 mg of each tissue sample, except for adipose and muscle tissues which required 100 mg) were weighed and then homogenized in 250 µl lysis buffer (LBA previously supplemented with 2% 1-thioglycerol) using a Tissue Ruptor (Qiagen, Hilden, Germany). 750 µl of Trizol reagent (Invitrogen, Madrid, Spain) was added to the homogenized samples, which were then vortexed for 10 seconds and incubated for 5 minutes at room temperature to permit complete dissociation of the nucleoprotein complex. Adipose tissue samples required an additional centrifugation step at 12.000g for 10 minutes at 4 ºC to remove insoluble material, and the fatty layer was removed and discarded while the cleared supernatant was transferred to a new tube.
200 µl of chloroform (Sigma, Madrid, Spain) was then added to the supernatant, which was subsequently shaken vigorously by hand for 15 seconds and incubated for 2 minutes at room temperature. This was followed by a centrifugation at 12.000g for 15 minutes at 4 ºC, after which the aqueous phase was transferred to a new tube. 35 µl of 2-propanol (Sigma) was added for each 100 µl of supernatant, samples were vortexed for 5 seconds, and the lysate was transferred to a ReliaPrep column and centrifuged at 14.000g for 30 seconds at room temperature. Subsequent RNA purification was as follows: 200 µl of wash solution was added followed by a centrifugation step at 14.000g
for 15 seconds at room temperature; 500 µl of RNA wash solution was added and followed by centrifugation at 14.000g for 30 seconds at room temperature; 300 µl of RNA wash solution was added followed by centrifugation at 20.000g for 2 minutes at room temperature. Finally, RNA was eluted with 30 µl of nuclease and RNase-free water in a last centrifugation step performed at 14.000g for 1 minute at room temperature. The concentration and purity of each sample was determined by spectrophotometer (ND2000; Nanodrop), and RNA samples were stored at -80 °C until use. The RNA was reverse transcribed using M-MLV reverse transcriptase (Invitrogen), as previously described (Victoria et al., 2010) .
Real-time RT-PCR
Specific primers and probes designed by the Universal ProbeLibrary (Roche Diagnostics, Sant Cugat del Valles, Spain) were used in a Light Cycler 2.0 (Roche Diagnostics) to determine the specific expression of the following genes: CAT, NESTIN, PEX1, PEX11G, PEX16, PPARG, RBFOX3/NeuN, SOD1, SOD2 (Table 2) , and three distinct BSCL2 transcripts (Figure 1 ). Real-time RT-PCR conditions are available upon request. Results were normalized to the 18S and RNA polymerase II genes using the 2 -∆∆ CT method (Livak and Schmittgen, 2001 ).
Cell culture
The SH-SY5Y neuroblastoma cell line was kindly provided by Dr. Jesús Rodríguez-Requena (Santiago de Compostela, Spain). Undifferentiated cells were maintained in a 1:1 mixture of Ham's F12 (cat. N4888, Sigma-Aldrich) and Minimum Essential Eagle's Medium (cat. M2279, Sigma-Aldrich) supplemented with 15% heat-inactivated fetal bovine serum (cat. 10270-106, Gibco), 1% GlutaMax-I™ (cat. 35050-061, Gibco), 100 units/ml penicillin, 100 µg/ml streptomycin (cat. 15140-122, Gibco), and 1% MEM non-essential amino acids solution (NEAA, cat. 11140050, Gibco) . Cells were grown in the presence of 5% CO2 in a humidified incubator at 37 ºC. The cell medium was replaced every 3 days, and the cells were sub-cultured once 90% confluence was reached. The cells were used at early passages (below P17) in all experiments.
Plasmids
A plasmid containing wild type human seipin fused to a myc tag (6x myc-wt seipin pCS2+MT) was generously provided by D. Ito (Keio University, Japan), and the myc fused seipin expression plasmid was described previously (Guillen-Navarro et al., 2013 plasmid is a replication-incompetent third generation vector, and is depicted in Figure 2 .
Full sequences were confirmed by sequencing.
Lentiviral transduction
Cells were seeded into 6-well plates (cat. 3516, Corning, Costar) at a density of 5.000 cells per cm 2 . The medium was removed twenty-four hours after seeding and the cells were washed with phosphate buffered saline (PBS). Viral particles (wild-type seipin), and the empty vector as a control, all with functional titers > 10 9 transducing units/ml produced by Cyagen Biosciences (Guangzhou, China) were added at a multiplicity of infection (MOI) of 200 viral particles/cell to a serum-free medium in the presence of Lentiblast A/B (1:100/1:1000, Oz Biosciences, Marseille, France). Serum was added 4 hours after initial infection (final infection volume 1 ml), the medium was removed twenty-four hours after infection, and the cells were washed with phosphate buffered saline (PBS). Cells were then cultured with typical SH-SY5Y medium and puromycin dihydrochloride (2 μg/ml final concentration, cat. P8833, Sigma-Aldrich) was subsequently added to the cell culture medium every 2-3 days until resistant stable cells were formed. Cells were then routinely grown as described above.
Differentiation
Stably transfected cells were seeded into 6-well plates at density of 10.000 cells per cm 2 and allowed to adhere for 2 days. Pre-differentiation was then started in DMEM high glucose (D5796, Sigma-Aldrich) supplemented with 3% heat-inactivated fetal bovine serum, 100 units/ml penicillin, and 100 µg/ml streptomycin with 10 µM retinoic acid (cat. R2625, Sigma-Aldrich), freshly prepared in DMSO and kept in the dark.
Undifferentiated cells were cultured in identical medium without retinoic acid. The second phase of differentiation was initiated after 3 days in these conditions (day 4)
with Neurobasal medium (cat. 21103-049, Gibco), 50 ng/ml BDNF (cat. 450-02, Peprotech), 1 mM dibutyryl-cAMP (cat. sc-201567A, Santa Cruz), 20 mM KCl (cat.
131494, Panreac), 10 µM retinoic acid, 1% B27 (cat. 17504-044, Gibco), 1% Glutamax 100x, 1% N-2 supplement (cat. 17502-048, Gibco), 100 units/ml penicillin, and 100 µg/ml streptomycin. Undifferentiated cells were maintained in high glucose DMEM, supplemented with 1% heat-inactivated fetal bovine serum, 100 units/ml penicillin, and 100 µg/ml streptomycin. The culture medium was changed every 2 days and supplemented with fresh additives. Differences in cell morphology between proliferative and differentiated cells were evaluated under phase contrast light microscopy with an Olympus IX51 microscope (Olympus Corporation, Tokyo, Japan) and photographed with an Olympus DP72 digital camera using the cellSens software (Olympus Corporation). Cells were harvested on day 8.
Immunostaining
The hypothalamus of the homozygous index case c.985C>T and of two control cases (male and female, 59 and 75 years at death, respectively) were fixed previously with Finally, they were mounted in aqueous medium containing 1:1000 DAPI (SigmaAldrich, cat. D9542).
Confocal fluorescence microscopy
Immunofluorescence staining was assessed with a Leica TCS SP2 confocal microscope 
Statistical analysis
Real-time PCR analyses were done by duplicates, and statistical significance was determined using a non-parametric Kruskal-Wallis test followed by a Mann-Whitney U post-hoc with Bonferroni correction. Correlations were tested using the Spearman R correlation coefficient and partial correlations were utilized to correlate two variables while adjusting for other one. Data are presented as mean ± SD with statistical significance set at p<0.05. All statistical analyses were performed using SPSS for Mac (release 22.0; SPSS, Chicago, IL, USA).
Results
Patterns of BSCL2 expression in human tissues
We evaluated the relative expression of seipin transcripts in the CNS, the peripheral nervous system (PNS), and extraneural tissues (ET) in 13 subjects ( Figure 3A , detailed with significance in Table 3 ). The total expression of BSCL2 was 6.9 times higher in the Figure 3B ). Within the CNS, the short transcript was primarily expressed in the caudate nucleus, the cerebellum, and the protuberance. Expression levels of BSCL2 transcripts across the primary brain divisions are summarized in Figure 3C .
A comparison of BSCL2 expression between men and women ( (Table 4) compared to women. Finally, BSCL2-201 expression in the pituitary and the right cerebellum are significantly lower in men than in women (-40%, p=0.003, and -67%, p=0.015, respectively) ( Table 4) .
Influence of age on BSCL2 expression
A comparison of BSCL2 expression between young and aged individuals (median age 61 years, Figure 5 ).
In vitro studies
Since the observed correlations do not imply causality, we differentiate SH-SY5Y cells stably transfected with BSCL2 into a neuronal model cell line in order to measure the expression of genes significantly correlated with BSCL2 in human brains.
Morphological changes were observed after 3-5 days (Figure 6 ), and many SH-SY5Y cells stopped proliferating and expanded an extensive network of long neurites. At the end of differentiation (day 7), cells were evenly distributed and developed a more rounded shape, forming clumps of cell bodies linked by long processes similar to axons ( Figure 6C ).
Neuronal differentiation was assessed by quantifying the mRNA expression levels of neurogenesis-related genes specific for neural progenitors (NESTIN) and mature neurons (NeuN/RBFOX3), playing an essential role in the differentiation and maturation of neural progenitor cells (Kim et al., 2009; . The results showed that the mRNA expression of both neuronal markers was detected in non-differentiated cells and significantly increased after 7 days of differentiation, pointing toward a more neuronal phenotype. NESTIN and NeuN/RBFOX3 increased approximately 4-to 5-fold and 2-to 10-fold, respectively ( Figure 7A-B) . The expression of the BSCL2-203 transcript was much higher in BSCL2-cells than in control cells (+3024%) ( Figure 8A ).
While there was no significant difference for PEX1, significantly higher relative expression was seen for PEX11G (+491%) ( Figure 8H ), PEX16 (+181%) ( Figure 8G ), PPARG (+93%) ( Figure 8C ), the antioxidant enzymes SOD1 (+33%) ( Figure 8D ), SOD2 (+25%) ( Figure 8E ), and CAT (+58%) ( Figure 8F ).
Confocal microscopy studies in human brains
Confocal microscopy was used to localize seipin and PEX16 expression in the hypothalami of healthy human brains and the PELD case. Image analysis revealed that seipin and PEX16 are expressed in neurons in the hypothalamic nuclei of both controls but not the PELD index case ( Figure 9A-C) . Interestingly, we only found cytoplasmic seipin in neurons (and not in astrocytes or oligodendrocytes). The main pattern observed in control brain regions was what we classified as the "granular profile," in which seipin is scattered throughout the neuronal cytoplasm and PEX16 appears to be closely intertwined in the free spaces ( Figure 9A -B) very close to seipin, with a shape resembling vesicles ( Figure 9D ). We also observed intranuclear PEX16 and seipin in control hypothalamus images ( Figure 9B ). Finally, the seipin observed in neurons was localized in the cytoplasm in samples from the Celia's Encephalopathy case, and the staining was clearly diffused within the neuronal body and the proximal segment of the axons. There were more seipin-containing nuclei in the Celia's Encephalopathy case compared to the control, while no PEX16 was found in the hypothalamus of this patient ( Figure 9C ).
Discussion
This study describes the differential expression of the BSCL2 in the human brain and To the best of our knowledge, this is the first time that BSCL2 transcript expression is mapped in the different regions of human brain. In mice, Garfield et al. (2012) using in situ hybridization to map the location of Bscl2 mRNA-positive cells, found that the regions with strong expression were the basal forebrain, hippocampus, hypothalamus, dorsal and ventral brainstems, with low expression in the cortex, moderate expression in the mibrain and no detectable expression in the caudate putamen. On the other hand, Liu et al. (2016) found a similar expression pattern of seipin in the CNS using immunohistochemical staining, however with some discrepancies like in the caudate putamen.
While in our study, we found highest BSCL2 expression in caudate, putamen, cerebellum and protuberance, and mostly in the forebrain and hindbrain. Inter-species differences could explain these discrepancies.
We have also found that the expression of seipin is noticeably reduced in the temporal lobe, amygdala and hypothalamus of the left hemisphere with age, all areas associated with memory and its consolidation, and the limbic system. Given that mitochondrial We investigated whether seipin is truly related to protective enzymes and peroxisomes in order to confirm our qPCR results in human brains. The significantly increased expression of the PEX11G, PEX16, SOD1, SOD2, CAT, and PPARG genes corroborated the relationship between seipin and the protective proteins to oxidative stress in differentiated SH-SY5Y cells overexpressing BSCL2. Confocal microscopy in the hypothalami of healthy human brains also confirmed the close juxtaposition of seipin and PEX16, the latter appearing with a vesicle-like shape. This key protein for peroxisomal biogenesis is required for the de novo synthesis of peroxisomes (Kim et al., 2006) and is known to target to the ER before being trafficked to peroxisomes (Hua et al., 2015) . Hofer et al. recently showed that PEX16 is a PPARG target gene whose expression regulates peroxisome number and lipid metabolism, and demonstrated that it is also required for adipogenesis (Hofer et al., 2017) . Studies in rodents have shown the beneficial effects of the pharmacological activation of peroxisome proliferator-activated receptors in Parkinson's disease and dyskinesia models (Barbiero et al., 2014; Grover et al., 2013) .
The profiles observed in the confocal images suggest that seipin is involved in peroxisome biogenesis, probably at an early phase. The juxtaposition of seipin and PEX16 observed in some neurons is consistent with the potential close proximity of peroxisomes and lipid droplet biogenesis areas (Binns et al., 2006) , suggesting that peroxisomes and seipin are intimately associated. We can further speculate that peroxisomes with vesicle-like shapes may be pre-peroxisomal vesicles emerging from the ER. It should be noted that the structure of the lipid droplets and the peroxisomes are similar, both emerge from the ER, and there is a dialogue between both organelles (Shai et al., 2016) . In this line, very recently and during the course of the review of this manuscript, Wang et al. 2018 identify in yeasts Pex30 as a factor cooperating with seipin in the biogenesis of both lipid droplets and pre-peroxisomal vesicles from the ER.
In our opinion, this recent Wang's paper reinforces our hypothesis about the role of seipin in peroxisomes biogenesis. On the other hand, peroxisomes are very abundant in neurons and play a key role in protection against oxidative stress, and are also critical for the synthesis of phospholipids. Finally, the peroxisome biomarker PEX16 is barely detectable in the brain of the PELD case, where seipin is also scarce. Taken together, these data may suggest that seipin is playing a role in peroxisome biogenesis as a regulator of peroxisomal protein sorting during the first steps of biogenesis from the ER, similarly to what happens in the nascent lipid droplets (Shai et al., 2016; Wang et al. 2018 ), or could act as an essential factor in the recruitment of other peroxisomal membrane proteins to the ER together with PEX16, which subsequently transports them to the peroxisomes (Kim and Mullen, 2013) . Relative expression of the encephalic and non-encephalic post-mortem tissues in young and old subjects, *: p<0.05. All samples were analyzed in duplicate, n = 13. Results were normalized for the 18S gene.
